Literature DB >> 12092655

AgNOR/P53 expression compared with different grades in bladder carcinoma.

M Karakök1, A Aydin, K Bakir, R Uçak, C Korkmaz.   

Abstract

OBJECTIVE: The aim of this study is to assess the relation between silver-strained nucleolar organizer regions (AgNOR)/P53 expression and urothelial neoplasm of the bladder which graded according to the WHO/ISUP tumor grading system.
METHODS: Transurethral resection materials (TUR) and cystectomy specimens from 52 patients with bladder urothelial carcinomas were stained by AgNORs and analyzed immunohistochemically using an avidinbiotin peroxidase method for p53 staining and also silver for AgNORs.
RESULTS: Nuclear p53 accumulation was determined in two of 5 LMP cases (%40), in 10 of 22 LGC (%45.4), and in 8 of 25 HGC (%32). Positivity of p53 accumulation was observed in 20 (%57.7) of all cases. There was no statistically significant relationship between AgNOR score of p53(+) and p53(-) cases. There was no correlation between LGC and LMP, also between LGC and HGC (p > 0.05), but a meaningful relationship was found between LMP and HGC (p = 0.03). Association between P53 and grade, AgNOR value and grade, p53 and AgNOR was found statistically insignificant.
CONCLUSIONS: Although we found a statistically significant correlation between AgNOR count of LMP and HGC, this study did not show a satisfying correlation between AgNOR, p53 and any grade of urothelial carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12092655     DOI: 10.1023/a:1015209612139

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

Review 1.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

2.  Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters.

Authors:  M Koyuncuoğlu; A Kargi; S Cingöz; Z Kirkali
Journal:  Cancer Lett       Date:  1998-04-24       Impact factor: 8.679

3.  Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.

Authors:  M Sanchez-Carbayo; M T Chulia; M Niveiro; I Aranda; A Mira; F Soria
Journal:  Anticancer Res       Date:  1999 Jul-Aug       Impact factor: 2.480

4.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.

Authors:  A Bergkvist; A Ljungqvist; G Moberger
Journal:  Acta Chir Scand       Date:  1965-10

5.  Paragonimus ohirai: identification of nucleolar organizer regions (NORs) and silver nitrate staining pattern in spermatogenesis.

Authors:  H Hirai
Journal:  Exp Parasitol       Date:  1988-12       Impact factor: 2.011

6.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

7.  Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors.

Authors:  R Vorreuther; R Hake; P Borchmann; S Lukowsky; J Thiele; U Engelmann
Journal:  Urol Int       Date:  1997       Impact factor: 2.089

8.  Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group.

Authors:  T J Liukkonen; P K Lipponen; M Helle; K E Jauhiainen
Journal:  Urol Res       Date:  1997

9.  Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.

Authors:  A Pich; L Chiusa; E Margaria
Journal:  Cancer Detect Prev       Date:  1995

10.  Maintenance of p53 alterations throughout breast cancer progression.

Authors:  A M Davidoff; B J Kerns; J D Iglehart; J R Marks
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

View more
  1 in total

1.  Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer.

Authors:  Sven Gunia; Matthias May; Katharina Scholmann; Stephan Störkel; Bernd Hoschke; Stefan Koch; Manfred Dietel; Glen Kristiansen
Journal:  Virchows Arch       Date:  2008-07-22       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.